147816-23-7
147816-23-7 结构式
基本信息
中文别名
盐酸头孢卡培萘酯 英文别名
(6R,7R)-(Pivaloyloxy)methyl 7-((Z)-2-(2-aminothiazol-4-yl)pent-2-enamido)-3-((carbamoyloxy)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-(((2Z)-2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl)amino)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, monohydrochloride, (6R-(6alpha,7beta(Z)))-
常见问题列表
生物活性
Cefcapene pivoxil hydrochloride，一种抗生素，具有口服活性的第三代头孢菌素，具有广谱的抗菌 (anti-bacterial) 活性。Cefcapene pivoxil hydrochloride 可用于脓疱病 (PPP) 的研究。靶点
IC50: bacterial
体内研究
Cefcapene pivoxil hydrochloride (oral administration; 100mg/kg; 4 days) is effective against invasive BLNAR strains in mice lung, stimates peak antibiotic concentrations of 1 to 2 μg/ml in the blood of mice from 30 to 120 min after intragastric administration.
| Animal Model: | Four-week-old female C57BL/6J mice with bacterial suspension in BSG (1×10 9 CFU) |
| Dosage: | 100 mg/kg |
| Administration: | Oral administration; 100mg/kg; 4 days |
| Result: | Was against H. influenzae colonization in mouse lung. |